Investment House LLC Sells 93,597 Shares of Kenvue Inc. $KVUE

Investment House LLC lowered its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 75.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 30,084 shares of the company’s stock after selling 93,597 shares during the period. Investment House LLC’s holdings in Kenvue were worth $488,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. AlphaCore Capital LLC boosted its stake in Kenvue by 9.9% in the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock worth $111,000 after purchasing an additional 476 shares during the period. Empirical Finance LLC lifted its holdings in shares of Kenvue by 1.8% in the second quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock worth $593,000 after buying an additional 491 shares in the last quarter. Proffitt & Goodson Inc. boosted its position in shares of Kenvue by 8.2% during the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock worth $143,000 after acquiring an additional 517 shares during the last quarter. Altus Wealth Group LLC grew its stake in Kenvue by 1.7% during the second quarter. Altus Wealth Group LLC now owns 31,398 shares of the company’s stock valued at $657,000 after acquiring an additional 524 shares in the last quarter. Finally, J.W. Cole Advisors Inc. increased its holdings in Kenvue by 3.8% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock valued at $324,000 after acquiring an additional 574 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Kenvue

In other news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. UBS Group decreased their price target on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Citigroup decreased their target price on Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, October 9th. Johnson Rice reissued a “neutral” rating on shares of Kenvue in a research note on Tuesday, October 28th. Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Finally, JPMorgan Chase & Co. decreased their price objective on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $20.23.

Kenvue Price Performance

NYSE:KVUE opened at $17.82 on Monday. The firm has a market capitalization of $34.14 billion, a price-to-earnings ratio of 23.76 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The business has a 50 day simple moving average of $17.05 and a 200-day simple moving average of $18.13. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.Kenvue’s quarterly revenue was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were issued a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date was Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.